NovoCure (NVCR) Leases (2019 - 2025)
Historic Leases for NovoCure (NVCR) over the last 7 years, with Q3 2025 value amounting to $48.4 million.
- NovoCure's Leases rose 7085.07% to $48.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.4 million, marking a year-over-year increase of 7085.07%. This contributed to the annual value of $27.1 million for FY2024, which is 2214.73% down from last year.
- Per NovoCure's latest filing, its Leases stood at $48.4 million for Q3 2025, which was up 7085.07% from $48.1 million recorded in Q2 2025.
- Over the past 5 years, NovoCure's Leases peaked at $48.5 million during Q1 2025, and registered a low of $16.5 million during Q3 2021.
- In the last 5 years, NovoCure's Leases had a median value of $26.3 million in 2023 and averaged $27.8 million.
- As far as peak fluctuations go, NovoCure's Leases plummeted by 2214.73% in 2024, and later surged by 7085.07% in 2025.
- NovoCure's Leases (Quarter) stood at $18.3 million in 2021, then rose by 29.17% to $23.6 million in 2022, then surged by 47.63% to $34.8 million in 2023, then decreased by 22.15% to $27.1 million in 2024, then soared by 78.47% to $48.4 million in 2025.
- Its Leases was $48.4 million in Q3 2025, compared to $48.1 million in Q2 2025 and $48.5 million in Q1 2025.